胰島素幫浦·持續血糖監測儀的全球市場 - 市場規模(各市場區隔)，佔有率，法規，償付，運作台數，預測(～2033年)

本報告提供全球胰島素幫浦·持續血糖監測儀市場相關調查分析，提供主要企業市場佔有率，主要趨勢，創新的產品與技術，競爭情形等資訊。

市場模式的主要內容如下列。

已上市的胰島素幫浦·持續血糖監測儀與不斷變化的競爭格局

• 主要的產業趨勢的考察
• 胰島素幫浦·持續血糖監測儀市場區隔的年度收益與市場預測(2015年～2033年)
• 有關各市場區隔的整體治療數，台數，平均銷售價格，市場金額的詳細的資料

世界，地區，國家層級的市場固有的考察

• 各地區分類的全球趨勢之特定市場定性資訊和國家/地區考慮因素
• 胰島素幫浦·持續血糖監測儀市場SWOT分析
• 胰島素幫浦·持續血糖監測儀市場競爭動態的考察和趨勢

透過對醫療保健系統的真實、全面的了解來促進市場理解。市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規形勢

對象企業

• Medtronic Plc
• Abbott Laboratories
• DexCom Inc
• Senseonics Holdings Inc
• Insulet Corp
• F. Hoffmann-La Roche Ltd
• Ypsomed Holding AG
• Tandem Diabetes Care Inc
• MannKind Corp
• 其他

Insulin Pumps and Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Patient Monitoring therapeutic area.

An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. An Insulin Pump consists of a battery run pump, an insulin reservoir and an infusion set with a tubing system for subcutaneous intervention.

Glucose monitoring devices are used for time defined or continuous measurement of blood glucose. Glucose monitoring does not include devices for ketone body testing or of any other blood constituents other than glucose. Blood glucose meters are tracked under this category.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Insuline Pumps and Continuous Glucose Monitors and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Insuline Pumps and Continuous Glucose Monitors market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Insuline Pumps and Continuous Glucose Monitors market.
• Competitive dynamics insights and trends provided Insuline Pumps and Continuous Glucose Monitors market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Abbott Laboratories, DexCom Inc, Senseonics Holdings Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, MannKind Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Insuline Pumps and Continuous Glucose Monitors marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Insuline Pumps and Continuous Glucose Monitors market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insuline Pumps and Continuous Glucose Monitors market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Insuline Pumps and Continuous Glucose Monitors market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.